Nectar Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

1,685.63

1,524.61

1,668.26

1,542.90

2,363.16

Operating profit

153.11

55.66

158.84

110.23

218.33

Interest

87.14

79.48

78.81

112.03

125.82

Gross profit

78.99

18.43

91.32

0.92

96.51

EPS (Rs)

0.22

-1.00

1.13

-3.26

1.34

Other income

13.03

42.24

11.29

2.72

4.01

Stock adjustment

-40.21

-41.64

14.97

102.80

-5.25

Raw material

1,242.45

1,200.84

1,206.88

1,028.40

1,834.03

Power and fuel

-

-

-

-

-

Employee expenses

84.67

77.78

74.55

73.37

81.00

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

245.61

231.97

213.02

228.10

235.05

Provisions made

-

-

-

-

-

Depreciation

60.72

59.12

56.97

60.25

60.77

Taxation

13.27

-18.24

9.03

-11.50

5.68

Net profit / loss

5.00

-22.46

25.32

-73.15

30.06

Extra ordinary item

-

-

-

-25.31

-

Prior year adjustments

-

-

-

-

-

Equity capital

22.43

22.43

22.43

22.43

22.43

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

9.08

3.65

9.52

7.14

9.24

GPM (%)

4.65

1.18

5.44

.06

4.08

NPM (%)

0.29

-1.43

1.51

-4.73

1.27